MedGenome

Oncology genomics / ctDNA research — Biomarker research & services.

Country: India

Growth Oncology genomics / ctDNA research

Coverage

	CN	EU	IN	US
diagnostics-medtech	✓	✓	✓	✓

Regulatorsfdaemanmpa

Verifiable facts

Fact	Value	Source
Funding	$47.5M Series E raised in July 2025	biovoicenews.com · inc42.com
Funding	$233M total funding raised across 9 rounds	inc42.com
Capacity	Targeting 1 million tests annually; currently processes 40,000–50,000 tests per month	fortuneindia.com · whalesbook.com
Certification	CAP-accredited laboratory; NABL-certified genomics laboratory	diagnostics.medgenome.com
Production site	Three labs in India: Bengaluru (central national reference lab), Mumbai (prenatal), and Delhi (NGS genomics lab)	fortuneindia.com · whalesbook.com
Production site	NGS laboratory in Foster City, California; presence in Singapore	genomeweb.com · prnewswire.com
Headcount	Approximately 1,000–1,300 employees	inc42.com
Revenue	₹407.0 Cr (FY25); current annual revenue is approximately ₹700 Cr (as of July 2026)	inc42.com · fortuneindia.com

Independent sources: biovoicenews.com · fortuneindia.com · genomeweb.com · inc42.com · prnewswire.com · whalesbook.com

Technologies

Name	Cluster	Risk
Companion diagnostics platforms	diagnostics-medtech	Low	→
Liquid biopsy & ctDNA diagnostics	diagnostics-medtech	Low	→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.